Only in Titles

Search results for: antibody

paperclip

#36484950   2022/12/09 To Up

Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.

G
Melissa A Greenwald, Eduard Grebe, Valerie Green, Alyce Linthurst Jones, Jeffrey M Linnen, Phillip Williamson, Michael P Busch, Matthew J Kuehnert

2554 related Products with: Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.

200ul200ul2000 Units

Related Pathways

    No related Items
paperclip

#36484857   2022/12/09 To Up

Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model.

Mouse IgG anti-disialoganglioside GD2 antibody-secreting mouse mesenchymal stem cells (anti-GD2-MSCs) were developed, and their anti-tumor effects were validated in an in vivo neuroblastoma mouse model.
Kosuke Kambe, Masafumi Iguchi, Mayumi Higashi, Shigeki Yagyu, Shigehisa Fumino, Tsunao Kishida, Osam Mazda, Tatsuro Tajiri

2375 related Products with: Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model.

25 µg25 µg100ul0.25 mg100 TESTS100ul0.2 mg1 ml0.2 mg100ug100ug100ul

Related Pathways

paperclip

#36484754   // To Up

[Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy].

P
A J Scheen, C Wallemacq, P Lancellotti

2054 related Products with: [Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy].

500 tests0.1 mg1 kit96 wellsOne 96-Well Microplate Ki1 kit96T

Related Pathways

    No related Items
paperclip

#36484518   2022/12/09 To Up

A programmable catalytic molecular nanomachine for highly sensitive protein and small molecule detection.

H
Na Li, Minhui Li, Mei Li

1071 related Products with: A programmable catalytic molecular nanomachine for highly sensitive protein and small molecule detection.

96 tests50 Test100ug20 ug2 Pieces/Box100ul100tests50 0.1 mg

Related Pathways

    No related Items
paperclip

#36484502   2022/12/09 To Up

Aseptic meningitis as an initial manifestation of primary Sjögren's syndrome.

A
Misako Higashida-Konishi, Mitsuhiro Akiyama, Tatsuya Shimada, Satoshi Hama, Tatsuhiro Oshige, Keisuke Izumi, Hisaji Oshima, Yutaka Okano

2536 related Products with: Aseptic meningitis as an initial manifestation of primary Sjögren's syndrome.

100ug100ug 100ul100ug50 ug 100ug48 samples100ug100ug

Related Pathways

    No related Items
paperclip

#36484484   2022/12/09 To Up

Safety and immunogenicity of a ChAd155-vectored RSV vaccine (ChAd155-RSV) in healthy RSV-seropositive children 12-23 months of age.

Safe and effective respiratory syncytial virus (RSV) vaccines remain elusive. This was a phase I/II trial (NCT02927873) of ChAd155-RSV, an investigational chimpanzee adenovirus-RSV vaccine expressing the F-, N- and M2-1 proteins, administered to 12-23-month-old RSV-seropositive children followed for 2 years post-vaccination.
Javier Díez-Domingo, Xavier Sáez-Llorens, Miguel A Rodriguez-Weber, Cristina Epalza, Archana Chatterjee, Cheng-Hsun Chiu, Chien-Yu Lin, Andrea A Berry, Federico Martinón-Torres, Fernando Baquero-Artigao, Joanne M Langley, José T Ramos Amador, Joseph B Domachowske, Li-Min Huang, Nan-Chang Chiu, Susanna Esposito, Philippe Moris, Thi Lien-Anh Nguyen, Vanja Nikic, Wayne Woo, Yingjun Zhou, Ilse Dieussaert, Amanda Leach, Antonio Gonzalez Lopez, Nicolas Vanhoutte

2444 related Products with: Safety and immunogenicity of a ChAd155-vectored RSV vaccine (ChAd155-RSV) in healthy RSV-seropositive children 12-23 months of age.

100 μg 100 G100 μg100 μg100ug100 μg50ul

Related Pathways

paperclip

#36484441   2022/12/09 To Up

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-Up Compared With Natural Infection.

We report 2-year persistence of immune response to Takeda's prophylactic purified formalin-inactivated whole Zika virus vaccine candidate (TAK-426) compared with that observed after natural infection.
Camilo J Acosta, Clemente Diaz, Francesco Nordio, Htay-Htay Han, Kelley J Moss, Kelly Bohning, Pradeep Kumar, Mengya Liu, Hetal Patel, Filippo Pacciarini, Vincent Mwangi, Elke Walter, Tim D Powell, Hana M El Sahly, Whitney R Baldwin, Joseph Santangelo, Evan J Anderson, Gary Dubin

1375 related Products with: Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-Up Compared With Natural Infection.

10 200 100 μg10050ug100ug/vial50 ug1 mg100 100 1 G250ug

Related Pathways

paperclip

#36484410   2022/12/09 To Up

Prostate cancer cell‑derived spondin 2 boosts osteogenic factor levels in osteoblasts via the PI3K/AKT/mTOR pathway.

P
Hongbo Wang, Ming Zhang, Wencheng Lu, Chao Yuan

1892 related Products with: Prostate cancer cell‑derived spondin 2 boosts osteogenic factor levels in osteoblasts via the PI3K/AKT/mTOR pathway.

5mg 100ul2ug

Related Pathways

    No related Items
paperclip

#36484373   2022/12/09 To Up

The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.

To evaluate cost-effectiveness of universal maternal cytomegalovirus (CMV) serologic screening and prenatal treatment and targeted and universal newborn CMV screening programs.
Hirosato Aoki, Ari Bitnun, Taito Kitano

1277 related Products with: The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan.

1 G1100 assays100 assays

Related Pathways

    No related Items
paperclip

#36484365   2022/12/09 To Up

Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis.

The coronavirus disease 2019 vaccine induces both antibody and T-cell immune responses and has been proven to be effective in preventing coronavirus disease 2019, including its severe disease form, in healthy individuals. However, the details of severe acute respiratory syndrome coronavirus-2 immunoglobulin-G antibody responses and severe acute respiratory syndrome coronavirus-2 specific T-cell responses in patients with sarcoidosis are unknown.
Ersan Atahan, Buket Çalışkaner Öztürk, Rüveyda Akçin, Suat Sarıbaş, Bekir Kocazeybek

1900 related Products with: Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis.

500 Units2000 Units100 μg10010020ug10mg100 μg1 mg

Related Pathways